Request Appointment
325 W 15th StNew York, NY 10011
Fax+1 212-604-6038
Overview of Dr. Rohs
Dr. Nicholas Rohs is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai Beth Israel. He received his medical degree from New York Medical College and has been in practice 15 years. He is one of 119 doctors at Mount Sinai Beth Israel and one of 81 doctors at Mount Sinai Morningside who specialize in Oncology. He has more than 10 publications and over 250 citings.
Education & Training
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2011 - 2014
New York Medical CollegeClass of 2011
Certifications & Licensure
NY State Medical License 2014 - 2028
Clinical Trials
- Dupilumab_Metastatic NSCLC Start of enrollment: 2021 Sep 10
Roles: Contact
Publications & Presentations
PubMed
- Incidence and treatment-modifying impact of immune checkpoint inhibitor-associated peripheral edema: a systematic review and meta-analysis.Anneliese Markus, Kazuya Tsuchiya, Toshiaki Takahashi, Evelyn Elias, Mako Koseki
JNCI Cancer Spectrum. 2026-06-03 - 4 citationsDiagnosis and management of bispecific T cell-engaging antibody toxicity: A primer for emergency physicians.Monica K Wattana, Jonathan Rowland, Aiham Qdaisat, Hannah Levavi, Theodora Anagnostou
Cancer Treatment Reviews. 2025-03-01 - 1 citationsCharacteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections.Medha Somisetty, Philip C Mack, Chih-Yuan Hsu, Yuanhui Huang, Jorge E Gomez
Clinical Lung Cancer. 2024-11-01
Press Mentions
How Air Pollution Can Trigger NSCLC in Never-SmokersOctober 4th, 2022- Is Disease-Free Survival a Meaningful Endpoint in NSCLC?June 25th, 2021
- Comprehensive Biomarker Testing for Lung Cancer: Who Needs It & What’s It For?August 17th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
